Risk
Why Battered Biotech May Be Turning Around
This cyclical sector has suffered, post-pandemic, but signs of a recovery are appearing.
Tag: Moderna
Asset Allocation
New York State Comptroller Files Diversity Proposals
Thomas DiNapoli is calling for more accountability from portfolio firms regarding corporate diversity, equity and inclusion.
Biotech Blues: Their Stocks Tank as Newly Public Firms Find Trouble
The urge to do an IPO was strong, and for some, much too early. Maybe staying private before maturing is a good idea for companies, especially biotech ones. That’s...
Market Moves
Good Vaccine News Has Immediate Impact on the Stock Market
A quarter of the S&P 500’s rise since May is linked to positive developments on a virus inoculation, UBS says.
Market Moves
How Little-Guy Investors Bested the Pros by Riding Popular Iffy Stocks
Goldman Sachs study shows that, since this year’s low point, ordinary market players shot past the smart money, 61% to 45%.